ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,094, issued on Aug. 26, was assigned to RADIUS PHARMACEUTICALS INC. (Boston).

"Polymorphic forms of RAD1901-2HCL" was invented by Michael Paul Cruskie Jr. (Florence, S.C.), Joshua Kyle Bolger (Florence, S.C.), Jonathan Blake Mckenzie (Latta, S.C.), Pratik Sheth (North Grafton, Mass.), Richard Edwards (Cambridge, Great Britain), Alex Eberlin (Cambridge, Great Britain) and Michael Markey (Northborough, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various polymorphic forms of RAD1901-2HCl, including three crystalline and amorphous forms, are prepared and characterized. Uses of the various polymorphic forms of RAD1901-2HCl for cancer treatment a...